TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Interest expense on outstanding debt
3Y CAGR
+33.0%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.77M | -24.2% |
| 2024 | $3.65M | -2.8% |
| 2023 | $3.76M | +219.6% |
| 2022 | $1.18M | - |
| 2021 | $0.00 | - |
| 2020 | $0.00 | - |
| 2019 | $0.00 | - |